PAPER
Synthesis of 6,6-Difluorohomopiperazines
225
Anal. Calcd for C19H22N2O5S2: C, 54.01; H, 5.25; N, 6.63; S, 15.18.
Found: C, 54.0; H, 5.28; N, 6.63; S, 14.8.
extracted with CH2Cl2. The combined organic layers were dried and
concentrated. The residue was washed several times with EtOAc–
n-heptane (1:2) and Et2O. The residue was dried in vacuum to give
6 as a white solid.
(R)-2-Methyl-1,4-bis-(toluene-4-sulfonyl)-[1,4]diazepan-6-one
(4)
Yield: 32 mg (37%); [ ]D +28.2 (c 1).
Sodium (105 mg, 4.54 mmol) was dissolved in MeOH (5 mL). The
mixture was added to a solution of 11 (720 mg, 1.89 mmol) in
MeOH (2 mL). The reaction mixture was heated to reflux for 0.5 h.
After cooling to r. t., the solvent was removed to give the crude so-
dium salt of 11 as a white solid.
1H NMR (CDCl3): = 1.06 (d, 3 H, J = 6.8 Hz, CH3), 2.44 (s, 3 H,
CH3), 2.46 (s, 3 H, CH3), 2.97 (dd, 1 H, J = 13.8, 3.8 Hz, H-3), 3.11
(ddd, 1 H, J = 23.2, 15.0, 8.1 Hz, H-5), 3.45 (ddd, 1 H, J = 24.6,
16.0, 8.2 Hz, H-7), 3.58 (br d, 1 H, J = 13.8 Hz, H-3), 4.04 (ddd, 1
H, J = 15.0, 15.0, 4.2 Hz, H-5), 4.15 (br dd, 1 H, J = 16.0, 15.0 Hz,
H-7), 4.21–4.26 (m, 1 H, H-2).
13C NMR (CDCl3): = 14.6, 21.5, 21.5, 47.0, 52.4, 55.4, 57.5,
122.5, 127.0, 127.1, 129.9, 130.1, 135.2, 136.8, 144.0, 144.3.
19F NMR (CDCl3) = –101.03 (d, 1 F, J = 244.7 Hz), –102.48 (d, 1
F, J = 244.7 Hz).
1,3-Dibromo-2-propanol (223 L, 2.1 mmol, 2.1 g/mL) was added
to a solution of the salt of 11 in EtOH (15 mL). The mixture was re-
fluxed overnight and then allowed to attain r.t. H2O (20 mL) was
added and the pH was adjusted to 10. The precipitate was filtered
off, washed with H2O and dried to give the crude 2 (683 mg, 83%)
as a diastereoisomeric mixture. The crude 2 was used in the next re-
action without further purification.
ESI-MS: m/z (%) = 459 [M + H+], 481 (100) [M + Na+].
To a solution of 2 (93 mg, 0.21 mmol) in CH2Cl2 (2 mL) was added
Dess–Martin periodinane (135 mg, 0.32 mmol) and the reaction
mixture was stirred for 1 h at r.t. Dowex-1-chloride (1 4-50, 1 g)
was washed with H2O, activated with Na2S2O3 (1 M, 4 20 mL),
washed with H2O and MeOH and dried in vacuum. The resin (1 g)
was added to the reaction mixture. After agitation overnight, the
resin was filtered off, TBD-methyl polystyrene 2% DVB (2.39
mmol/g, 2.1 mmol) was added and the resulting suspension was ag-
itated for an additional 1.5 h. The resin was removed, washed with
CH2Cl2 and the combined filtrates were concentrated to give 4 as a
white solid.
6,6-Difluoro-[1,4]diazepane dihydrobromide (7)
Method A
A suspension of 5 (80 mg, 0.2 mmol) and phenol (72 mg, 0.8 mmol)
in HOAc–HBr (3 mL, 30 wt%) was heated to 100 °C for 200 s in a
pressure tube using microwave irradiation. The solvent was re-
moved in vacuum and the residue triturated with Et2O, washed with
EtOH and Et2O to give 7 as a white solid.
Yield: 57 mg (95%).
Method B
Yield: 78.9 mg (85%); [ ]D +14.8 (c 1).
A suspension of 5 (1.46 g, 3.3 mmol) and phenol (1.23 g, 13.1
mmol) in HOAc–HBr (20 mL, 30 wt%) was heated to 110 °C in a
sealed tube. After 30 min, the mixture was allowed to attain r.t., the
solvent was removed in vacuum and the residue triturated with
Et2O, washed with EtOH and Et2O to give 7 as a white solid.
1H NMR (CDCl3): = 1.26 (d, 3 H, J = 7.0 Hz, CH3), 2.42 (s, 3 H,
CH3), 2.44 (s, 3 H, CH3), 3.20 (dd, 1 H, J = 13.9, 3.3 Hz, H-3), 3.56
(d, 1 H, J = 16.9 Hz, H-5,-7), 3.89 (mAB, 1 H, J = 17.9 Hz, H-7,-5),
3.93 (d, 1 H, J = 13.9 Hz, H-3), 3.97 (mAB, 1 H, H-7,-5), 4.11 (dd, 1
H, J = 16.9, 1.2 Hz, H-5,-7), 4.44–4.48 (m, 1 H, H-2).
Yield: 884 mg (90%).
13C NMR (CDCl3): = 15.3, 21.5, 50.5, 52.6, 57.5, 57.8, 126.9,
127.0, 129.9, 130.0, 135.2, 136.6, 144.1, 144.2, 203.8.
1H NMR (DMSO-d6): = 3.45 (s, 4 H, H-2,-3), 3.86 (t, 4 H,
J = 13.0 Hz, H-5,-7).
13C NMR (DMSO-d6): = 44.4, 49.6, 119.6.
19F (DMSO-d6): = –93.79 (s, 2 F).
Anal. Calcd for C20H24N2O5S2: C, 55.03; H, 5.54; N, 6.42; S, 14.69.
Found: C, 55.40; H, 5.59; N, 6.43; S, 14.8.
ESI-MS: m/z (%) = 137 [M + H+], 178 (100) [M + CH3CN + Na+].
6,6-Difluoro-1,4-bis(toluene-4-sulfonyl)-[1,4]diazepane (5)
To a solution of 3 (351 mg, 0.83 mmol) in CH2Cl2 (10 mL) was add-
ed DAST (671 mg, 4.15 mmol) in two portions over 30 min. The re-
action mixture was stirred overnight at r.t. and carefully quenched
with sat. aq NaHCO3. The aqueous layer was extracted with CH2Cl2
and the combined organic phases were dried and concentrated. The
crude yellow solid was recrystallized from EtOAc to yield 5 as a
white solid.
Anal. Calcd for C5H12Br2F2N2: C, 20.16; H, 4.06; N, 9.40. Found:
C, 20.1; H, 4.22; N, 9.25.
(R)-6,6-Difluoro-2-methyl-[1,4]diazepane dihydrobromide (8)
Following method A 8 was obtained as a white solid.
Yield: 51 mg (82%); [ ]D +27.2 (c 0.5).
Following method B 8 was obtained as a white solid.
Yield: 720 mg (70%).
Yield: 297 mg (80%).
1H NMR (CDCl3): = 2.45 (s, 6 H, CH3), 3.42 (s, 4 H, H-2,-3), 3.69
1H NMR (DMSO-d6): = 1.27 (d, 1 H, J = 6.7 Hz, CH3), 3.12 (dd,
1 H, J = 14.3, 10.3 Hz, H-3), 3.45 (dd, 1 H, J = 14.3, 2.0 Hz, H-3),
3.64–3.76 (m, 3 H, H-7,-5,-2), 3.80–3.93 (m, 2 H, H-5,-7).
13C NMR (DMSO-d6): = 17.4, 45.9, 49.4, 50.7, 53.7, 120.3.
19F NMR (DMSO-d6): = –90.79 (d, 1 F, J = 247.7 Hz), –92.34 (d,
1 F, J = 247.7 Hz).
(t, 4 H, J = 12.3 Hz, H-5,-7).
13C NMR (CDCl3): = 21.5, 52.4, 54.8, 122.2, 127.1, 130.1, 135.4,
144.3.
19F NMR (CDCl3): = –103.00 (s, 2 F).
ESI-MS: m/z (%) = 445 [M + H+], 467 (100) [M + Na+], 508 [M +
CH3CN + Na+].
ESI-MS: m/z (%) = 151(100) [M + H+], 192 [M + CH3CN + Na+],
Anal. Calcd for C20H24F2N2O4S2: C, 51.34; H, 4.99; N, 6.30; S,
14.42. Found: C, 51.4; H, 5.03; N, 6.16; S, 14.2.
383 [M + M + HBr + H+].
Anal. Calcd for C6H14Br2F2N2: C, 23.10; H, 4.52; N, 8.98. Found:
C, 23.1; H, 4.72; N, 8.83.
(R)-6,6-Difluoro-2-methyl-1,4-bis-(toluene-4-sulfonyl)-[1,4]di-
azepane (6)
DAST (116mg, 0.72mmol) was added to a solution of 4 (79 mg,
0.18 mmol) in CH2Cl2 (2 mL). The mixture was stirred at r.t. over-
night. The reaction was carefully quenched with sat. NaHCO3 and
6,6-Difluoro-[1,4]diazepane (9)
A suspension of 5 (60 mg, 0.2 mmol) and (polystyrylmethyl)trime-
thylammonium bicarbonate (240 mg, 1.2 mmol, loading: 5 mmol/g)
Synthesis 2002, No. 2, 223–226 ISSN 0039-7881 © Thieme Stuttgart · New York